Hyo Jung Choi1, Min Soo Byun1, Dahyun Yi1, Young Min Choe2, Bo Kyung Sohn3, Hye Won Baek1, Jun Ho Lee1, Hyun Jung Kim1, Ji Young Han1, Eun Jin Yoon4, Yu Kyeong Kim4, Jong Inn Woo1, Dong Young Lee5. 1. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea. 2. Department of Neuropsychiatry, Ulsan University Hospital, Ulsan, Republic of Korea. 3. Department of Neuropsychiatry, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. 4. Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. 5. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: selfpsy@snu.ac.kr.
Abstract
OBJECTIVES: Although many preclinical studies have suggested the possible linkage between dyslipidemia and cerebral amyloid deposition, the association between serum lipid measures and cerebral amyloid-beta (Aβ) deposition in human brain is still poorly known. We aimed to investigate the association in cognitively normal (CN) elderly individuals. DESIGN: Cross-sectional study. SETTING: University hospital dementia clinic. PARTICIPANTS: 59 CN elderly. MEASUREMENTS: The study measures included comprehensive clinical and neuropsychological assessment based on the CERAD protocol, magnetic resonance imaging and (11)C-labelled Pittsburgh Compound B positron emission tomography scans, and quantification for serum lipid biomarkers. RESULTS: Multiple linear regression analyses showed that a higher serum triglycerides level was associated with heavier global cerebral Aβ deposition even after controlling age, sex, and apolipoprotein E ε4 genotype. Serum apolipoprotein B also showed significant positive association with global cerebral Aβ deposition, but the significance disappeared after controlling serum triglycerides level. No association was found between other lipid measures and global cerebral Aβ deposition. CONCLUSIONS: The findings suggest that serum triglycerides are closely associated with cerebral amyloidosis, although population-based prospective studies are needed to provide further evidence of the causative effect of triglycerides on cerebral amyloidosis.
OBJECTIVES: Although many preclinical studies have suggested the possible linkage between dyslipidemia and cerebral amyloid deposition, the association between serum lipid measures and cerebral amyloid-beta (Aβ) deposition in human brain is still poorly known. We aimed to investigate the association in cognitively normal (CN) elderly individuals. DESIGN: Cross-sectional study. SETTING: University hospital dementia clinic. PARTICIPANTS: 59 CN elderly. MEASUREMENTS: The study measures included comprehensive clinical and neuropsychological assessment based on the CERAD protocol, magnetic resonance imaging and (11)C-labelled Pittsburgh Compound B positron emission tomography scans, and quantification for serum lipid biomarkers. RESULTS: Multiple linear regression analyses showed that a higher serum triglycerides level was associated with heavier global cerebral Aβ deposition even after controlling age, sex, and apolipoprotein E ε4 genotype. Serum apolipoprotein B also showed significant positive association with global cerebral Aβ deposition, but the significance disappeared after controlling serum triglycerides level. No association was found between other lipid measures and global cerebral Aβ deposition. CONCLUSIONS: The findings suggest that serum triglycerides are closely associated with cerebral amyloidosis, although population-based prospective studies are needed to provide further evidence of the causative effect of triglycerides on cerebral amyloidosis.
Authors: Lauren E Oberlin; Kirk I Erickson; Rachel Mackey; William E Klunk; Howard Aizenstein; Brian J Lopresti; Lewis H Kuller; Oscar L Lopez; Beth E Snitz Journal: Brain Behav Immun Date: 2021-03-15 Impact factor: 19.227
Authors: Megan M Bernath; Sudeepa Bhattacharyya; Kwangsik Nho; Dinesh Kumar Barupal; Oliver Fiehn; Rebecca Baillie; Shannon L Risacher; Matthias Arnold; Tanner Jacobson; John Q Trojanowski; Leslie M Shaw; Michael W Weiner; P Murali Doraiswamy; Rima Kaddurah-Daouk; Andrew J Saykin Journal: Neurology Date: 2020-05-01 Impact factor: 11.800
Authors: Katarina Nägga; Anna-Märta Gustavsson; Erik Stomrud; Daniel Lindqvist; Danielle van Westen; Kaj Blennow; Henrik Zetterberg; Olle Melander; Oskar Hansson Journal: Neurology Date: 2017-12-01 Impact factor: 9.910
Authors: Austin M Reilly; Andy P Tsai; Peter B Lin; Aaron C Ericsson; Adrian L Oblak; Hongxia Ren Journal: Nutrients Date: 2020-09-29 Impact factor: 5.717